SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Total Non-current Liabilities
All obligations due after more than one year.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Total Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total non-current liabilities of $1.61M in Q1 FY2026
Q1 FY2026 total non-current liabilities was $1.61M.
Context
- Total non-current liabilities amounted to 0.6% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 206.12M USD
- Year-over-year change
- —
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 206.12M | — |
Total Non-current Liabilities vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so total non-current liabilities is compared through growth and share of total assets rather than absolute size.
- Total non-current liabilities amounts to 0.6% of total assets for SGP, versus a peer median of 14.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $6.84B USD | +6.2% | -1.4% | 21.8% | |
| Jun 2026 | $5.53B USD | +0.7% | +26.7% | 39.9% | |
| Jun 2026 | $135.71M USD | -4.9% | -33.9% | 14.7% | |
| Mar 2026 | $103.27M USD | +1.2% | +7.7% | 14.1% | |
| Apr 2026 | $37.76M USD | -3.3% | +16.4% | 8.4% | |
| Mar 2026 | $37.64M USD | -5.7% | +4.7% | 34.3% | |
| Mar 2026 | $20.28M USD | -9.8% | -25.0% | 7.0% | |
| Mar 2026 | $9.32M USD | -15.2% | -38.8% | 3.1% | |
| Mar 2026 | CHF 3.47M CHF | +65.9% | -70.5% | 1.4% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $1.61M USD | — | — | 0.6% |
| Peer median (excluding SGP) | — | -3.3% | -1.4% | 14.1% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.